Clinical Trial Update: Rasburicase for Hyperuricemia [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study of rasburicase for hyperuricemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia

Drugs mentioned

• Rasburicase (Elitek) (rasburicase)

Snippet

Sponsor: Sanofi | Conditions: Nutritional and Metabolic Diseases | Phase 2 | Status: COMPLETED